相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Enhanced Inflammasome Activity in Patients with Psoriasis Promotes Systemic Inflammation
Deepti Verma et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation
Gang Bian et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
High-content screening identifies inhibitors of oxidative stress-induced parthanatos: cytoprotective and anti-inflammatory effects of ciclopirox
Zsolt Regdon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation
Bing Wu et al.
IMMUNITY (2021)
Function and regulation of the divisome for mitochondrial fission
Felix Kraus et al.
NATURE (2021)
The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages
Wenyun Zeng et al.
SCIENTIFIC REPORTS (2021)
Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics
Soumya Ranjan Mishra et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)
Management of psoriasis as a systemic disease: what is the evidence?
N. J. Korman
BRITISH JOURNAL OF DERMATOLOGY (2020)
Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent
Hongxuan Feng et al.
ACTA PHARMACEUTICA SINICA B (2020)
Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis
Gaku Tsuji et al.
CELL DEATH DISCOVERY (2020)
A Critical Role of the IL-1 beta-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis
Yihua Cai et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis
H. -J. Shi et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice
Guoliang Deng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer
Jing Zhou et al.
THERANOSTICS (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
Yi Huang et al.
EMBO MOLECULAR MEDICINE (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Andrew Blauvelt et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria
Pedro Urquiza et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Richard Gordon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
PGC-1 in Melanoma: A Key Factor for Antioxidant Response and Mitochondrial Function
Margalida Torrens-Mas et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis
Natasha Irrera et al.
CLINICAL SCIENCE (2017)
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation
Michael J. Primiano et al.
JOURNAL OF IMMUNOLOGY (2016)
ASC filament formation serves as a signal amplification mechanism for inflammasomes
Mathias S. Dick et al.
NATURE COMMUNICATIONS (2016)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3
Reiner K. W. Mailer et al.
SCIENTIFIC REPORTS (2015)
The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation
Masahiro Okada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid
Anna Balato et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
David A. Martin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility
Maria Carlstrom et al.
EXPERIMENTAL DERMATOLOGY (2012)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus
Yue Zhao et al.
NATURE (2011)
Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis
Jonathan W. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component
Yin-Ku Lin et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells
Liying Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The activity of caspase-1 is increased in lesional psoriatic epidermis
Claus Johansen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis
AK Gupta et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
Ciclopirox protects mitochondria from hydrogen peroxide toxicity
SJ Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist
J Shepherd et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)